prostate cancer

Medivation prostate cancer drug impresses in pre-chemo study
Yahoo/Reuters
Wed, 01/29/14 - 09:29 am
Medivation
prostate cancer
Xtandi
Slowing Sales for Johnson & Johnson's Zytiga May Be Good News for Medivation
Motley Fool
Thu, 01/23/14 - 08:22 am
JNJ
Zytiga
Medivation
Xtandi
prostate cancer
Progenics Likely To Announce Positive Prostate Cancer Data In January
Seeking Alpha
Tue, 01/7/14 - 09:28 am
prostate cancer
Progenics
Celldex Therapeutics
Seattle Genetics
CytRx
Adcetris
The Provenge Vaccine, A Hedge Fund Manager And The SEC
Pharmalot
Wed, 12/4/13 - 08:47 am
SEC
prostate cancer
Provenge
Dendreon
Johnson & Johnson Vs. Medivation In Prostate Cancer Race
Seeking Alpha
Mon, 11/18/13 - 08:19 am
JNJ
Medivation
prostate cancer
Xtandi
Astellas
Zytiga
Dendreon, Zogenix, and Ampio Pharmaceuticals Could Be Big Movers Today
Motley Fool
Mon, 10/28/13 - 09:33 am
Dendreon
Zogenix
Ampio Pharmaceuticals
prostate cancer
Medivation
Zytiga
Provenge
Zohydro ER
Ampion
Here's Why Medivation Jumped Higher This Week
Motley Fool
Sat, 10/26/13 - 11:26 am
Medivation
Xtandi
prostate cancer
Medivation, Astellas prostate cancer drug meets trial goals
Yahoo/Reuters
Tue, 10/22/13 - 08:07 am
Medivation
prostate cancer
Astellas
Enzalutamide
AstraZeneca to co-promote J&J prostate cancer drug in Japan
Yahoo/Reuters
Fri, 10/11/13 - 08:47 am
JNJ
AstraZeneca
Japan
prostate cancer
abiraterone
Recent Developments With Northwest Bio Hint At Big Move In 3 To 4 Months
Seeking Alpha
Thu, 10/3/13 - 05:30 pm
Northwest Biotherapeutics
DCVax
prostate cancer
brain cancer
Dendreon: Time To Prove Itself Or Perish
Seeking Alpha
Thu, 10/3/13 - 09:11 am
Dendreon
prostate cancer
JNJ
Provenge
Medivation
How Johnson & Johnson Plans to Win the Prostate Cancer Battle
Motley Fool
Sat, 09/28/13 - 12:17 pm
Zytiga
prostate cancer
JNJ
Can Xtandi Become the Go-To Prostate Drug?
Motley Fool
Sat, 09/21/13 - 10:29 am
Xtandi
prostate cancer
Medivation
Astellas
Dendreon jumps on winning European approval for prostate-cancer treatment
Marketwatch
Tue, 09/17/13 - 12:34 pm
Europe
prostate cancer
Dendreon
Provenge
Dendreon's Provenge: A Major Focus At The European Cancer Congress 2013
Seeking Alpha
Mon, 09/16/13 - 10:56 am
Dendreon
Provenge
Europe
prostate cancer
Bristol-Myers Squibb: Another Brick In The Wall
Seeking Alpha
Mon, 09/16/13 - 10:07 am
Bristol-Myers Squibb
Yervoy
prostate cancer
Bristol-Myers skin cancer drug Yervoy misses goal in study of additional, prostate cancer use
Yahoo/AP
Thu, 09/12/13 - 09:21 am
prostate cancer
Yervoy
Bristol-Myers Squibb
Dendreon: Crushed By JNJ/Medivation Or By Own Management?
Seeking Alpha
Mon, 09/9/13 - 05:19 pm
JNJ
Medivation
Dendreon
Provenge
Xtandi
Zytiga
prostate cancer
Norway's Algeta says prostate cancer drug makes solid U.S. debut
Reuters
Wed, 08/28/13 - 11:38 am
Algeta
prostate cancer
Xofigo
This Biotech’s Single Egg Will Never Hatch
Motley Fool
Sun, 08/18/13 - 11:54 am
Dendreon
Provenge
prostate cancer

Pages